<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    pp
   </journal-id>
   <journal-title-group>
    <journal-title>
     Pharmacology &amp; Pharmacy
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2157-9423
   </issn>
   <issn publication-format="print">
    2157-9431
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/pp.2024.1512026
   </article-id>
   <article-id pub-id-type="publisher-id">
    pp-138452
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Chemistry 
     </subject>
     <subject>
       Materials Science, Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Curative Effect of Spondias mombin L. against Carbon Tetrachloride-Induced Liver Damage in Rat
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Assi Narcisse Roméo
      </surname>
      <given-names>
       Boni
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Agnon Prisca
      </surname>
      <given-names>
       Djoupo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Konan
      </surname>
      <given-names>
       Kouassi
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Jean-David
      </surname>
      <given-names>
       N’Guessan
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aTraining and Research Unit of Sciences and Technologies, Alassane Ouattara University, Bouaké, Côte d’Ivoire
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aLaboratory of Biochemistry, Faculty of Medicine, Alassane Ouattara University, Bouaké, Côte d’Ivoire
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aLaboratory of Biology and Health, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     06
    </day> 
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    12
   </issue>
   <fpage>
    478
   </fpage>
   <lpage>
    489
   </lpage>
   <history>
    <date date-type="received">
     <day>
      7,
     </day>
     <month>
      November
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      22,
     </day>
     <month>
      November
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      22,
     </day>
     <month>
      December
     </month>
     <year>
      2024
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Background:</b> Oxidative stress is implicated in liver disease pathogenesis. Liver injuries are traditionally treated with stem bark from Spondias mombin. In our previous study, this plant demonstrated promising in vitro antioxidant activities. 
    <b>Objective:</b> The purpose of this study was to evaluate the antioxidant and hepatocurative activity of methanolic extract of S. mombin (MESPM) through in vivo studies. 
    <b>Methods:</b> Thirty rats were divided into five groups containing six rats each. Group I was the normal control, group II was the negative control and the other groups were experimental groups. Rats in groups II - V received, firstly, 2 mL/kg/day of carbon tetrachloride (CCl
    <sub>4</sub>) intraperitoneally, for three days to induce oxidative stress and hepatotoxicity. On the following day, groups IV and V were administered MESPM orally for eleven consecutive days, respectively, at 200 and 400 mg/kg/day. Silymarin (50 mg/kg) was used as a standard (group II: positive control). Serum biochemical parameters and in vivo antioxidant activity were measured using standard procedures. Gross and histopathological studies were also performed. 
    <b>Results:</b> CCl
    <sub>4</sub> induced oxidative stress was manifested by an increase in TBARS level as well as a decrease in FRAP level and DPPH radicals scavenging percentage compared to normal control (P &lt; 0.001). Furthermore, CCl
    <sub>4</sub> hepatotoxicity caused significant increases in ALT, AST, ALP, bilirubin levels, with a decline in total proteins (P &lt; 0.001). However, as a result of treatment with silymarin or MESPM (400 mg/kg), enzyme activities, bilirubina and total protein levels, were significantly reversed. Oxidative stress parameters were also restored. The macroscopic and histopathological changes of hepatocytes against CCl
    <sub>4</sub> confirmed that MESPM was effective. 
    <b>Conclusion:</b> The results confirm MESPM’s traditional use as a hepatocurative agent, probably due to its antioxidant properties.
   </abstract>
   <kwd-group> 
    <kwd>
     Oxidative Stress
    </kwd> 
    <kwd>
      Hepatocurative
    </kwd> 
    <kwd>
      Antioxidant
    </kwd> 
    <kwd>
      Spondias mombin
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>The liver is a major organ which plays a central role in many essential physiological processes, thus maintaining metabolic homeostasis, secretion, storage, and detoxification of diverse exogenous and endogenous xenobiotics <xref ref-type="bibr" rid="scirp.138452-1">
     [1]
    </xref>. Furthermore, the liver, due to its strategic location in the body, is continually exposed to various xenobiotics, environmental pollutants and chemotherapeutic agents which can lead to liver diseases, such as hepatitis, cirrhosis, alcohol liver disease, fatty liver, jaundice <xref ref-type="bibr" rid="scirp.138452-2">
     [2]
    </xref>. According to the World Health Organization <xref ref-type="bibr" rid="scirp.138452-3">
     [3]
    </xref>, hepatitis B and C lead to chronic disease in hundreds of millions of people and are the most common cause of liver cirrhosis, liver cancer and viral hepatitis-related deaths. In Côte d’Ivoire, testing and treatment for hepatitis B and C are very limited, with prevalence estimates at 12% and 5%, respectively <xref ref-type="bibr" rid="scirp.138452-4">
     [4]
    </xref>.</p>
   <p>Oxidative stress, which is produced by an imbalance between free radical formation and cells’ ability to neutralize them, has been implicated in the pathogenesis and pathophysiology of liver disease <xref ref-type="bibr" rid="scirp.138452-5">
     [5]
    </xref>-<xref ref-type="bibr" rid="scirp.138452-7">
     [7]
    </xref>. Therefore, antioxidants have a role in scavenging free radicals, inhibiting lipid peroxidation and by other mechanisms and protecting the hepatic cells from liver toxicity <xref ref-type="bibr" rid="scirp.138452-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.138452-9">
     [9]
    </xref>. During the past few decades, there has been increasing interest in naturally occurring antioxidants in view of the adverse side effects associated with synthetic antioxidants <xref ref-type="bibr" rid="scirp.138452-10">
     [10]
    </xref>.</p>
   <p>Spondias mombin is native to the humid plains of the Amazon rainforest and extends across Africa, tropical America, Brazil, the Caribbean and other tropical rainforests of the world <xref ref-type="bibr" rid="scirp.138452-11">
     [11]
    </xref>. In our preliminary works, an acute toxicity study demonstrated no significant toxicity of the methanolic extract of plant stem bark in a rat model. The methanolic extract of S. mombin also possessed antioxidant effects in in vitro studies <xref ref-type="bibr" rid="scirp.138452-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.138452-13">
     [13]
    </xref>. Moreover, in Côte d’Ivoire and other sub-Saharan countries, a decoction of the bark of S. mombin is used in the treatment [of liver diseases such as jaundice, severe jaundice, hepatitis and liver failure <xref ref-type="bibr" rid="scirp.138452-14">
     [14]
    </xref> <xref ref-type="bibr" rid="scirp.138452-15">
     [15]
    </xref>.</p>
   <p>We conducted this study in order to validate the traditional use of stem bark from S. mombin in liver diseases. A laboratory rat model was used to assess the hepatocurative potential and antioxidant properties of methanolic extract of S. mombin against carbon tetrachloride-induced oxidative stress and liver damage.</p>
  </sec><sec id="s2">
   <title>2. Materials and Methods</title>
   <sec id="s2_1">
    <title>2.1. Plant Material</title>
    <p>The stem bark of Spondias mombin was collected from Afféry (Region of Adzopé, south of Côte d’Ivoire). The plant was identified by her vernacular name and later authenticated by the National Floristic Center, University Felix Houphouët-Boigny, Côte d’Ivoire. The collected plant material was air dried in darkness at room temperature (20˚C). Stem barks were cut up and stored in tight-sealed dark containers until needed.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Chemicals</title>
    <p>Carbon tetrachloride (CCl<sub>4</sub>) and sylimarin were obtained, respectively, from Merck (Darmstadt, Germany) and Sigma Aldrich (St Louis, MO, USA).</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. Preparation of Extract</title>
    <p>One hundred grams (100 g) of washed, air-dried powdered stem of the plants were extracted with 1.5 L of methanol at room temperature for 48 hours with stirring at intervals. The methanolic solution obtained was filtered using a Buckner funnel and Whatman No 1. It was concentrated to dryness at 40˚C using a rotary evaporator under reduced pressure. The dried extracts were stored at 4˚C for subsequent analysis. The methanolic extract of the stem bark of Spondias mombin was named MESPM.</p>
   </sec>
   <sec id="s2_4">
    <title>2.4. Experimental Design</title>
    <p>
     <xref ref-type="bibr" rid="scirp.138452-"></xref>Albino rats (130 - 170 g) of both sexes were used for the experiment and resided in the animal rearing house of Ecole Normale Supérieure d’Abidjan (Côte d’Ivoire). They were provided with tap water and regular food with maintained 12 h day and night cycle, at a room temperature of 27˚C ± 1˚C. All experiments were performed in accordance with regulations on experimental animal administration issued by the Ethical Guidelines of the University Committee on Animal Resources (Côte d’Ivoire). Doses of the plant were selected based on our previous acute toxicity study <xref ref-type="bibr" rid="scirp.138452-12">
      [12]
     </xref>. Thirty animals were divided into 5 groups consisting of 6 animals each (<xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>). Group I served as a normal control group and received any treatment for fourteen (14) days. Group II served as a negative control group, receiving, intraperitoneally (i.p), only 2 mL/kg/day of 30% CCl<sub>4</sub> dissolved in liquid paraffin, on days 1, 2 and 3. Group III referred as a positive control group, was injected with CCl<sub>4</sub> (day 1, 2 and 3), and orally received silymarin (50 mg/kg/day) for eleven (11) consecutive days. The experimental groups IV and V, after intoxication with 30% CCl<sub>4</sub>, the first 3 days, were given, orally, 200 mg/kg/day and 400 mg/kg/day of MESPM, respectively for 11 consecutive days.</p>
    <p>Twenty-four hours after the last treatment i.e., on 15<sup>th</sup> day, animals were anaesthetized using light ether anesthesia and blood was collected from the retro orbital plexus. The blood samples were allowed to clot and the serum was separated by centrifugation at 2500 rpm for 15 min at 37˚C and kept at –4<sup>°</sup>C. Furthermore, the liver was rapidly excised, rinsed in ice-cold saline, and was fixed in 10% formalin solution for histopathological evaluation while a 10% w/v homogenate was prepared using 0.15M KCl, centrifuged at 3000 g for 20 min at 4˚C. This supernatant was ultimately used to assess parameters.</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>Figure 1. Experimental Design. The animals were distributed into five groups, consisting of 6 animals each. Oxidative stress and liver damage were induced by administering 2 mL/kg/day, i.p., of CCl<sub>4</sub> diluted in liquid paraffin.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2501528-rId19.jpeg?20241225034222" />
    </fig>
   </sec>
   <sec id="s2_5">
    <title>2.5. Assessment of in Vivo Antioxidant Potential</title>
    <p>Three techniques were used to quantify the in vivo antioxidant activity in liver tissue and serum samples against CCl<sub>4</sub>-induced oxidative stress in rats. TBARS (thiobarbituric acid reactive substances) level was assessed through the process of Ohkawa et al. <xref ref-type="bibr" rid="scirp.138452-16">
      [16]
     </xref>. The total antioxidant power was evaluated using FRAP (ferric reducing antioxidant power) assay developed by Benzie and Strain <xref ref-type="bibr" rid="scirp.138452-17">
      [17]
     </xref>. DPPH free radicals scavenging activity of serum samples was determined according to the protocol of Hasani et al. <xref ref-type="bibr" rid="scirp.138452-18">
      [18]
     </xref>.</p>
   </sec>
   <sec id="s2_6">
    <title>2.6. Biochemical Assays in Serum</title>
    <p>To evaluate biochemical markers in liver injury, alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total protein and total bilirubin were measured in plasma samples using an autoanalyzer (Roche/ INTEGRA) and commercial assay kits (COBAS INTEGRA). The manufacturer’s protocol was followed for all estimations.</p>
   </sec>
   <sec id="s2_7">
    <title>2.7. Gross and Histopathological Studies</title>
    <p>The livers of rats were macroscopically examined for signs of damage, followed by histopathological analysis of liver samples fixed in 10% formalin solution. Afterward, livers were dissected into approximately 5 mm-thick pieces. These sections were dehydrated in gradual ethanol concentration, cleared in xylene and finally embedded in paraffin wax. The paraffin embedded tissues were sectioned (4 μm to 5 μm) serially using a rotary microtome. Tissue slices were then stained with eosin and hematoxylin for light microscopic observations.</p>
   </sec>
   <sec id="s2_8">
    <title>2.8. Statistical Analysis</title>
    <p>All data are presented as a mean with standard error (SEM). Graphpad Prism version 5.0 (San Diego, United States of America) was used to analyze the data. To analyze data sets, one-way analysis of variance (ANOVA) was used, and statistical analysis was performed using Tukey’s multiple comparison. At p &lt; 0.05, differences were considered statistically significant.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <sec id="s3_1">
    <title>3.1. Effect of Methanolic Extract of S. mombin on Oxidative Stress Parameters in CCl<sub>4</sub>-Treated Rats</title>
    <p>In this study, in vivo antioxidant activity of methanolic extract of S. mombin (MESPM) in serum and liver homogenate was assessed by measuring TBARS levels, FRAP values, and percentage inhibition of DPPH radicals. As shown in <xref ref-type="table" rid="table1">
      Table 1
     </xref>, administration of CCl<sub>4</sub> in rats caused higher level (p &lt; 0.001) of TBARS in liver tissue by 312.10% compared to normal group. Also, a significant decrease (p &lt; 0.001) in the FRAP values and percentage inhibition of DPPH radicals in serum, respectively, by around 47.08% and 68.30%, was observed in CCl<sub>4</sub> intoxicated group (negative control) compared to normal control. However, post-treatment, both with MESPM, at 400 mg/kg of body weight and silymarin (50 mg/kg body weight), in CCl<sub>4</sub>-intoxicated rats, reduced significantly (p &lt; 0.001) hepatic concentration of TBARS, respectively by 43.20% and 39.90%, whereas exhibited a significant increase (p &lt; 0.05) of percentage inhibition of DPPH radicals as well as total antioxidant power, compared to negative control group without bringing them back to normal values. After treatment with MESPM (400 mg/kg of body weight) and silymarin, serum DPPH radical scavenging activity returned to normal levels, except for TBARS concentrations.</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.138452-"></xref>Table 1. Effect of treatment with methanolic extract of S. mombin (MESPM) on oxidative stress parameters in CCl<sub>4</sub> intoxicated rats.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="50.14%"><p style="text-align:center">Treatment</p></td> 
       <td class="custom-bottom-td acenter" width="28.11%"><p style="text-align:center">TBARS</p><p style="text-align:center">(nmol/g)</p></td> 
       <td class="custom-bottom-td acenter" width="24.10%"><p style="text-align:center">DPPH</p><p style="text-align:center">(%)</p></td> 
       <td class="custom-bottom-td acenter" width="26.03%"><p style="text-align:center">FRAP</p><p style="text-align:center">(µmol/L)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="50.14%"><p style="text-align:center">Normal control</p></td> 
       <td class="custom-top-td acenter" width="28.11%"><p style="text-align:center">161.2 ± 18.15***</p></td> 
       <td class="custom-top-td acenter" width="24.10%"><p style="text-align:center">32.12 ± 2.50**</p></td> 
       <td class="custom-top-td acenter" width="26.03%"><p style="text-align:center">422 ± 29.08***</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.14%"><p style="text-align:center">Negative control</p></td> 
       <td class="acenter" width="28.11%"><p style="text-align:center">664.3 ± 60.48<sup>###</sup></p></td> 
       <td class="acenter" width="24.10%"><p style="text-align:center">10.18 ± 2.19<sup>###</sup></p></td> 
       <td class="acenter" width="26.03%"><p style="text-align:center">223.3 ± 15.44<sup>###</sup></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.14%"><p style="text-align:center">CCl<sub>4</sub> + silymarin (50 mg/kg)</p></td> 
       <td class="acenter" width="28.11%"><p style="text-align:center">399.3 ± 36.40***<sup>##</sup></p></td> 
       <td class="acenter" width="24.10%"><p style="text-align:center">26.46 ± 4.14*</p></td> 
       <td class="acenter" width="26.03%"><p style="text-align:center">372.8 ± 20.23**</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.14%"><p style="text-align:center">CCl<sub>4</sub> + MESPM (200 mg/kg)</p></td> 
       <td class="acenter" width="28.11%"><p style="text-align:center">489.9 ± 13.89*<sup>###</sup></p></td> 
       <td class="acenter" width="24.10%"><p style="text-align:center">22.32 ± 3.69<sup>#</sup></p></td> 
       <td class="acenter" width="26.03%"><p style="text-align:center">295.2 ±19.05<sup>##</sup></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.14%"><p style="text-align:center">CCl<sub>4</sub> + MESPM (400 mg/kg)</p></td> 
       <td class="acenter" width="28.11%"><p style="text-align:center">377.3 ± 29.40***<sup>##</sup></p></td> 
       <td class="acenter" width="24.10%"><p style="text-align:center">25.89 ± 3.77*</p></td> 
       <td class="acenter" width="26.03%"><p style="text-align:center">326.1 ± 19.11*<sup>#</sup></p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>
     <xref ref-type="bibr" rid="scirp.138452-"></xref>The values of the parameters studied are expressed as mean ± standard deviation, n = 6. The symbols (*#) represent statistical significance. *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001 denotes a significant difference between the negative control group and the other experimental groups. #p &lt; 0.05; ##p &lt; 0.01; ###p &lt; 0.001 denotes a significant difference between the normal control group and the treatment groups.</p>
   </sec>
   <sec id="s3_2">
    <title>3.2. Effect of Methanolic Extract of S. mombin (MESPM) on Liver Enzymes, Total Bilirubin and Total Proteins against CCl<sub>4</sub> Induced Liver Toxicity in Rats</title>
    <p>The effect of methanolic extract of stem barks of S. mombin (MESPM) on serum biochemical parameters in CCl<sub>4</sub>-intoxicated rats is summarized in <xref ref-type="table" rid="table2">
      Table 2
     </xref>. The ALT, AST, ALP, and total bilirubin levels in the CCl<sub>4</sub>-intoxicated group (negative control) were significantly raised (p &lt; 0.001) in serum, respectively by 132.65%, 126.98%, 164.83%, and 465.21%, whereas total proteins were decreased (27.61%) as compared to normal control. Serum marker enzyme activity and bilirubin level in rats treated after CCl<sub>4</sub> intoxication with 200 mg/kg of body weight (except for AST) and 400 mg/kg of body weight of MESPM, are significantly reduced, while total proteins concentration increased compared to negative control. Furthermore, only rats treated with MESPM, at 400 mg/kg of body weight and silymarin (50 mg/kg of body) reversed these biochemical parameters, bringing them closer to normal control values (p &gt; 0.05).</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.138452-"></xref>Table 2. Effect of treatment with methanolic extract of S. mombin on markers of liver damage in CCl<sub>4</sub> intoxicated rats.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="26.62%"><p style="text-align:center">Treatment</p></td> 
       <td class="custom-bottom-td acenter" width="17.01%"><p style="text-align:center">ALT</p><p style="text-align:center">(U/L)</p></td> 
       <td class="custom-bottom-td acenter" width="15.59%"><p style="text-align:center">AST</p><p style="text-align:center">(U/L)</p></td> 
       <td class="custom-bottom-td acenter" width="17.01%"><p style="text-align:center">ALP</p><p style="text-align:center">(U/L)</p></td> 
       <td class="custom-bottom-td acenter" width="14.17%"><p style="text-align:center">Bilirubin</p><p style="text-align:center">(g/L)</p></td> 
       <td class="custom-bottom-td acenter" width="15.60%"><p style="text-align:center">Total proteins (g/L)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="26.62%"><p style="text-align:center">Normal control</p></td> 
       <td class="custom-top-td acenter" width="17.01%"><p style="text-align:center">56.11 ± 6.43***</p></td> 
       <td class="custom-top-td acenter" width="15.59%"><p style="text-align:center">169.7 ±16.52***</p></td> 
       <td class="custom-top-td acenter" width="17.01%"><p style="text-align:center">85.60 ± 13.40***</p></td> 
       <td class="custom-top-td acenter" width="14.17%"><p style="text-align:center">0.46 ± 0.06***</p></td> 
       <td class="custom-top-td acenter" width="15.60%"><p style="text-align:center">70.80 ± 2.20***</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="26.62%"><p style="text-align:center">Negative control</p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">223.6 ± 32.74<sup>###</sup></p></td> 
       <td class="acenter" width="15.59%"><p style="text-align:center">385.2 ± 33.74<sup>###</sup></p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">226.7 ± 49.59<sup>###</sup></p></td> 
       <td class="acenter" width="14.17%"><p style="text-align:center">2.56 ± 0.37 <sup>###</sup></p></td> 
       <td class="acenter" width="15.60%"><p style="text-align:center">51.25 ± 2.75<sup>###</sup></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="26.62%"><p style="text-align:center">CCl<sub>4</sub> + silymarin (50 mg/kg)</p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">70.17 ± 10.99***</p></td> 
       <td class="acenter" width="15.59%"><p style="text-align:center">224.4 ± 9.73**</p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">77.00 ±14.75***</p></td> 
       <td class="acenter" width="14.17%"><p style="text-align:center">0.94 ± 0.34**</p></td> 
       <td class="acenter" width="15.60%"><p style="text-align:center">67.78 ± 3.42**</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="26.62%"><p style="text-align:center">CCl<sub>4</sub> + MESPM (200 mg/kg)</p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">137.4 ± 16.09*<sup>#</sup></p></td> 
       <td class="acenter" width="15.59%"><p style="text-align:center">286.5 ± 34.48<sup> #</sup></p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">164.0 ± 24.01*<sup>#</sup></p></td> 
       <td class="acenter" width="14.17%"><p style="text-align:center">1.10 ± 0.34*</p></td> 
       <td class="acenter" width="15.60%"><p style="text-align:center">65.35 ± 1.31*</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="26.62%"><p style="text-align:center">CCl<sub>4</sub> + MESPM (400 mg/kg)</p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">64.72 ± 6.58***</p></td> 
       <td class="acenter" width="15.59%"><p style="text-align:center">213.8 ± 23.04***</p></td> 
       <td class="acenter" width="17.01%"><p style="text-align:center">110.5 ± 9.43**</p></td> 
       <td class="acenter" width="14.17%"><p style="text-align:center">1.01 ± 0.29*</p></td> 
       <td class="acenter" width="15.60%"><p style="text-align:center">66.75 ± 1.75**</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>The values of the parameters studied are expressed as mean ± standard deviation, n = 6. The symbols (*#) represent statistical significance. *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001 denotes a significant difference between the negative control group and the other experimental groups. #p &lt; 0.05; ##p &lt; 0.01; ###p &lt; 0.001 denotes a significant difference between the normal control group and the treatment groups.</p>
   </sec>
   <sec id="s3_3">
    <title>3.3. Gross and Histopathological Observations</title>
    <p>Gross necropsy and histopathological study were performed on the livers to observe any irregularities or anomalies on the structure. <xref ref-type="fig" rid="fig2">
      Figure 2
     </xref> shows macroscopic observations. A normal control group liver displayed a reddish-brown color, a regular surface, and a normal anatomical structure. No lesions are visible to the naked eye (<xref ref-type="fig" rid="fig2(a)">
      Figure 2(a)
     </xref>). According to <xref ref-type="fig" rid="fig2(b)">
      Figure 2(b)
     </xref>, liver treated with only CCl<sub>4</sub> showed an unregular surface with a rounded shape, dented by large cysts, suggesting severe hepatocellular damage. Its surface is dotted with white spots which are signs of necrosis. Post treatment of intoxicated liver with either the high dose of MESPM (400 mg/kg of body weight) and silymarin presented a pale liver color with minimal white spots and micronodules (<xref ref-type="fig" rid="figFigures 2(d)-(e))">
      Figures 2(d)-(e))
     </xref>. No serious lesions such as macronodules or cysts are detectable, indicating a regression of lesions induced by CCl<sub>4</sub>.</p>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.138452-"></xref>Figure 2. Macroscopic liver appearance of rats treated with methanolic extract of S. mombin (MESPM) and silymarin after CCl<sub>4</sub> intoxication. (a) Liver of normal control group; (b) Liver of negative control group; (c) Liver of rat poisoning with CCl<sub>4</sub> followed by treatment with 200 mg/kg of body weight of MESPM; (d) Liver intoxicated with CCl<sub>4</sub> and treated with 50 mg/kg of body weight of MESPM; (e) Liver intoxicated with CCl<sub>4</sub> and treated with 400 mg/kg of body weight of MESPM. Yellow arrows represent macronodules (cysts); blue arrows represent whitish spots of necrosis; green arrows display micronodules.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2501528-rId20.jpeg?20241225034226" />
    </fig>
    <fig id="fig3" position="float">
     <label>Figure 3</label>
     <caption>
      <title>Figure 3. Hepatic histological analyses of the effect of methanolic extract of S. mombin and silymarin on CCl<sub>4</sub>-induced liver injuries in rat. (a)-(b): Normal control group; (c)-(d) CCl<sub>4</sub> intoxicated liver tissue (negative control); (e)-(f): Positive control group (CCl<sub>4</sub> + silymarin); (g)-(h): CCl<sub>4</sub> + 200 mg/kg; (i)-(j): CCl<sub>4</sub> + 400 mg/kg. Hematoxylin &amp; Eosin staining, (a), (c), (e), (g), (i): x 100; (b), (d), (f), (h), (j): x 400. The yellow arrow denotes central lobular vein dilatation while red arrows denote necrosis. The blue and green arrows represent respectively, inflammatory infiltrates and ballooning hepatocytes.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2501528-rId21.jpeg?20241225034226" />
    </fig>
    <p>Histopathological examination of the liver section from the normal control group showed no abnormalities in hepatic cellular architecture (<xref ref-type="fig" rid="fig3(a)">
      Figure 3(a)
     </xref>, <xref ref-type="bibr" rid="scirp.138452-#f3">
      (Figure 3(b)
     </xref>). Liver cells spaced by sinusoids were arranged radically from central vein. In the negative control group, a very significant dilatation of the centrilobular vein and numerous foci of inflammation around this vein is noted (<xref ref-type="fig" rid="fig3(c)">
      Figure 3(c)
     </xref>). Liver tissue’s trabecular organization is completely unrecognizable due to lysis and loss of cellular cohesion. Furthermore, necrotic lesions are present throughout the entire photomicrograph and significant inflammation foci are identified. In addition, hypercolored nuclei of hepatocytes are a sign of pyknosis (<xref ref-type="fig" rid="fig3(d)">
      Figure 3(d)
     </xref>). The photomicrograph of the liver of rats intoxicated with CCl<sub>4</sub> then treated with 400 mg/kg of MESPM or silymarin indicated ballooned hepatocytes and moderate dilatation of the centrilobular vein are noted as well as relative lesions of necrosis and inflammation infiltrates (<xref ref-type="fig" rid="figFigures 3(g)-(j)">
      Figures 3(g)-(j)
     </xref>). Post-treatment with these doses generally resulted in a strong regression of CCl<sub>4</sub>-induced hepatocyte lesions in rats compared to rats in negative controls.</p>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>Liver is damaged by several agents such as chemicals including alcohol, drugs, and viruses <xref ref-type="bibr" rid="scirp.138452-2">
     [2]
    </xref>. In our investigation, carbon tetrachloride induced hepatotoxicity. The choice of this toxicant is motivated by the fact that it is commonly used as a model for the screening of anti-hepatotoxic and/or hepatoprotective activities of drugs <xref ref-type="bibr" rid="scirp.138452-19">
     [19]
    </xref>. Moreover, the liver damage caused by CCl<sub>4</sub> is similar to that produced by viral hepatitis <xref ref-type="bibr" rid="scirp.138452-20">
     [20]
    </xref>. Several reports demonstrated the implication of oxidative stress in the pathogenesis of liver diseases <xref ref-type="bibr" rid="scirp.138452-5">
     [5]
    </xref>-<xref ref-type="bibr" rid="scirp.138452-7">
     [7]
    </xref>. Therefore, antioxidants may protect against reactive free radicals caused by oxidative stress. In our previous work, methanolic extract of stem barks of S. mombin indicated a relative high content of total polyphenols (343.5 ± 6.44 mg gallic acid/g) and flavonoids (11.28 ± 0.45 mg quercetin/g) as well as strong in vitro antioxidant activities through different tests such as DPPH scavenging activity, inhibition of lipid peroxidation, and reducing power <xref ref-type="bibr" rid="scirp.138452-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.138452-13">
     [13]
    </xref>. In the present study, the in vivo antioxidant activity of MESPM against CCl<sub>4</sub> induced oxidative stress was evaluated. As an indicator of lipid peroxidation, TBARS reflects oxidative stress directly <xref ref-type="bibr" rid="scirp.138452-21">
     [21]
    </xref>. CCl<sub>4</sub> injections significantly increased the level of TBARS. In fact, CCl<sub>4</sub> induces hepatic damage by producing toxic reactive trichloromethyl and trichloromethyl peroxide radicals along with liver microsomes containing cytochrome P450 <xref ref-type="bibr" rid="scirp.138452-22">
     [22]
    </xref>. These reactive radicals further bind to unsaturated fatty acids in the membranes of hepatocytes, mitochondria and endoplasmic reticulum, inducing a chain lipid peroxidation process that leads first to damage and then to death of hepatocytes and intracellular structures <xref ref-type="bibr" rid="scirp.138452-23">
     [23]
    </xref>. After propagation of the peroxidation process, lipids are finally degraded into small molecules such as malondialdehyde (MDA) or 4-hydroxynonenal (HNE), which are highly reactive aldehydes that can form protein and DNA adducts <xref ref-type="bibr" rid="scirp.138452-24">
     [24]
    </xref> <xref ref-type="bibr" rid="scirp.138452-25">
     [25]
    </xref>. On the other hand, MESPM attenuated significantly the level of lipid peroxidation, suggesting a hepatocurative effect by decreasing oxidative stress in the CCl<sub>4</sub>-induced acute liver injury. A variety of other techniques have been developed to determine the antioxidant capacity of plasma, such as the ferric reducing antioxidant of plasma (FRAP) and the DPPH radical scavenging activity. In different clinical studies of oxidative stress-related pathological conditions, both methods are widely recognized and used <xref ref-type="bibr" rid="scirp.138452-26">
     [26]
    </xref> <xref ref-type="bibr" rid="scirp.138452-27">
     [27]
    </xref>. Data obtained by DPPH and FRAP assays indicate that administration of MESPM in intoxicated rats effectively inhibits oxidative stress by increasing DPPH radical scavenging percentage and FRAP level. The increase in plasma antioxidant capacity is probably attributed to the elevated levels of exogenous antioxidants acquired following treatment with S. mombin extract. The peroxidation of membrane lipids by CCl<sub>4</sub> is known to significantly alter their physical properties. In particular, peroxidation alters lipid-lipid interactions, ion gradients, membrane fluidity, and membrane permeability <xref ref-type="bibr" rid="scirp.138452-28">
     [28]
    </xref>. Disruption of the hepatocellular plasma membrane leads to the release of enzymes normally present in the cytosol into the blood circulation. Accordingly, liver transaminases (AST, ALT) and ALP activities were significantly increased in rats administered only with CCl<sub>4</sub> compared to the normal control group. Elevation of bilirubin and reduction of total protein levels were also observed in the CCl<sub>4</sub>-treated group (negative control). The excretory function of the liver can be determined by blood bilirubin levels. It is known that abnormal increase in serum bilirubin indicates hepatobiliary disease and severe disturbance of hepatocellular architecture <xref ref-type="bibr" rid="scirp.138452-29">
     [29]
    </xref>, while reduction in serum total proteins can be due to impaired protein synthesis due to liver tissue damage <xref ref-type="bibr" rid="scirp.138452-30">
     [30]
    </xref>. MESPM treatment in CCl<sub>4</sub>-treated rats restores normal membrane integrity, recovers liver secretory and synthesis function by bringing these biochemical parameters closer to normal values. Histological examination supports previous biochemical findings. In CCl<sub>4</sub>-treated rats, histopathological analysis revealed ballooning, degeneration of hepatocytes, inflammatory infiltration and severe hepatocellular necrosis. In comparison to normal control, oral administration of MESPM, especially at the highest dose (400 mg/kg), and silymarin restores the architecture of liver tissue.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>Based on the results obtained in this study, it is concluded that the hepatocurative properties of the methanolic extract of S. mombin (MESPM) on carbon tetrachloride induced liver damages in rats were demonstrated by the restoration to normal values of the various biochemical parameters and histological abnormalities of liver tissues. The curative effects of S. mombin may be attributed to its antioxidant properties. Its traditional use as a liver injury treatment is also justified by these results. A further study is required to isolate the active principle of the plant that acts as an effective antihepatotoxic agent.</p>
  </sec><sec id="s6">
   <title>Acknowledgements</title>
   <p>One part of this study was carried out at the Department of Fundamental and Clinical Biochemistry, Pasteur Institute of Côte d’Ivoire (IPCI). Authors wish to thank Prof. Allico Joseph Djaman, Head of this Department.</p>
  </sec><sec id="s7">
   <title>Authors’ Contributions</title>
   <p>ANR B designed the experiments, supervised the study and wrote the first draft of the manuscript. AP D contributed to data analysis and interpretation. K K contributed to animal handling and experimentation. JD N critically reviewed the manuscript. All the authors contributed to revising the manuscript.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.138452-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Iranshahy, M., Iranshahi, M., Abtahi, S.R. and Karimi, G. (2018) The Role of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatoprotective Activity of Natural Products: A Review. Food and Chemical Toxicology, 120, 261-276. &gt;https://doi.org/10.1016/j.fct.2018.07.024
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rao, K.M., Reddy, R.V., Vangoori, Y. and Sundharam, J.M. (2014) Evaluation of Hepatoprotective (Preventive&amp;Curative) Activity of Leaves Extract of Rosa Centifolia on Experimental Animal Models. Asian Journal of Pharmaceutical and Clinical Research, 7, 105-107.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     World Health Organization (2024) Hepatitis. &gt;https://www.who.int/health-topics/hepatitis#tab=tab_1
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Enel, C., Desgrées du Loû, A., N’Dri Yoman, T., Danel, C. and Larmarange, J. (2015) Les hépatites virales B et C en Côte d’Ivoire: L’urgence d’une dynamisation de la lutte. Journal Africain d’Hépato-Gastroentérologie, 9, 94-98. &gt;https://doi.org/10.1007/s12157-015-0596-6
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ivanov, A., Bartosch, B., Smirnova, O., Isaguliants, M. and Kochetkov, S. (2013) HCV and Oxidative Stress in the Liver. Viruses, 5, 439-469. &gt;https://doi.org/10.3390/v5020439
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Geetha, A., Lakshmi Priya, M.D., Jeyachristy, S.A. and Surendran, R. (2007) Level of Oxidative Stress in the Red Blood Cells of Patients with Liver Cirrhosis. Indian Journal of Medical Research, 126, 204-210.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cederbaum, A.I., Lu, Y. and Wu, D. (2009) Role of Oxidative Stress in Alcohol-Induced Liver Injury. Archives of Toxicology, 83, 519-548. &gt;https://doi.org/10.1007/s00204-009-0432-0
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Trest, A. (2022) Significant Role of Antioxidants in the Treatment of Liver Disease. Oxidants and Antioxidants in Medical Science, 11, 1.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Li, S., Tan, H., Wang, N., Zhang, Z., Lao, L., Wong, C., et al. (2015) The Role of Oxidative Stress and Antioxidants in Liver Diseases. International Journal of Molecular Sciences, 16, 26087-26124. &gt;https://doi.org/10.3390/ijms161125942
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Atmaca, M., Bilgin, H.M., Obay, B.D., Diken, H., Kelle, M. and Kale, E. (2011) The Hepatoprotective Effect of Coumarin and Coumarin Derivates on Carbon Tetrachloride-Induced Hepatic Injury by Antioxidative Activities in Rats. Journal of Physiology and Biochemistry, 67, 569-576. &gt;https://doi.org/10.1007/s13105-011-0103-5
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Duvall, C.S. (2006) On the Origin of the Tree Spondias mombin in Africa. Journal of Historical Geography, 32, 249-266. &gt;https://doi.org/10.1016/j.jhg.2005.02.001
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Boni A.N., Kouassi, K., Ayebe, E.A., Yapi, H.F., Djaman, A.J. and Nguessan, J.D. (2015) In Vivo Antioxidant Activity of Methanolic Extract of Stem Bark of Spondias mombin L. on Carbon Tetrachloride Induced Oxidative Stress in Wistar Rats. Journal of Chemical and Pharmaceutical Research, 7, 1232-1239.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Boni, A.N., Ahua, K.M., Kouassi, K., Yapi, H., Djaman, A.J. and Nguessan, JD. (2014) Comparison of In-Vitro Antioxidant Activities and Total Phenolic Contents in Water and Methanol Extracts of stems BARK of Spondias mombin. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 5, 1457-1468.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kerharo, J. and Bouquet, A. (1950) Plantes médicinales et toxiques de la Côte-d’Ivoire—Haute-Volta. Mission d’étude de la pharmacopée indigène en AOF, Edition Vigot et Frères.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Diafouka, A.J.P. (1997) Analyse des usages des plantes médicinales dans 4 régions de Congo-Brazzaville. Thèse de doctorat ès sciences, Université libre de Bruxelles.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ohkawa, H., Ohishi, N. and Yagi, K. (1979) Assay for Lipid Peroxides in Animal Tissues by Thiobarbituric Acid Reaction. Analytical Biochemistry, 95, 351-358. &gt;https://doi.org/10.1016/0003-2697(79)90738-3
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Benzie, I.F.F. and Strain, J.J. (1996) The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Analytical Biochemistry, 239, 70-76. &gt;https://doi.org/10.1006/abio.1996.0292
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hasani, P., Yasa, N., Vosough-Ghanbari, S., Mohammadirad, A., Dehghan, G. and Abdollahi, M. (2007) In Vivo Antioxidant Potential of Teucrium Polium, as Compared to Α-Tocopherol. Acta Pharmaceutica, 57, 123-129. &gt;https://doi.org/10.2478/v10007-007-0010-z
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Prophet, E.P., Mills, B., Arrington, J.B. and Sobin, L.H. (1992) Laboratory Methods in Histology. American Registry of Pathology.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ponmari, G., Annamalai, A., Gopalakrishnan, V.K., Lakshmi, P.T.V. and Guruvayoorappan, C. (2014) NF-κB Activation and Proinflammatory Cytokines Mediated Protective Effect of Indigofera caerulea Roxb. on CCl
     <sub>4</sub> Induced Liver Damage in Rats. International Immunopharmacology, 23, 672-680. &gt;https://doi.org/10.1016/j.intimp.2014.10.021
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gan, D., Ma, L., Jiang, C., Wang, M. and Zeng, X. (2012) Medium Optimization and Potential Hepatoprotective Effect of Mycelial Polysaccharides from Pholiota Dinghuensis Bi against Carbon Tetrachloride-Induced Acute Liver Injury in Mice. Food and Chemical Toxicology, 50, 2681-2688. &gt;https://doi.org/10.1016/j.fct.2012.05.003
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Li, L., Li, W., Kim, Y. and Lee, Y.W. (2013) Chlorella vulgaris Extract Ameliorates Carbon Tetrachloride-Induced Acute Hepatic Injury in Mice. Experimental and Toxicologic Pathology, 65, 73-80. &gt;https://doi.org/10.1016/j.etp.2011.06.003
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Popović, D., Kocić, G., Katić, V., Zarubica, A., Janković Veličković, L., Ničković, V.P., et al. (2019) Anthocyanins Protect Hepatocytes against CCl
     <sub>4</sub>-Induced Acute Liver Injury in Rats by Inhibiting Pro-Inflammatory Mediators, Polyamine Catabolism, Lipocalin-2, and Excessive Proliferation of Kupffer Cells. Antioxidants (Basel), 8, Article No. 451. &gt;https://doi.org/10.3390/antiox8100451
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Levy, G.N. and Brabec, M.J. (1984) Binding of Carbon Tetrachloride Metabolites to Rat Hepatic Mitochondrial DNA. Toxicology Letters, 22, 229-234. &gt;https://doi.org/10.1016/0378-4274(84)90071-7
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kadiiska, M.B., Gladen, B.C., Baird, D.D., Germolec, D., Graham, L.B., Parker, C.E., et al. (2005) Biomarkers of Oxidative Stress Study II: Are Oxidation Products of Lipids, Proteins, and DNA Markers of CCl
     <sub>4</sub> Poisoning? Free Radical Biology and Medicine, 38, 698-710. &gt;https://doi.org/10.1016/j.freeradbiomed.2004.09.017
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chrzczanowicz, J., Gawron, A., Zwolinska, A., de Graft-Johnson, J., Krajewski, W., Krol, M., et al. (2008) Simple Method for Determining Human Serum 2,2-Diphenyl-1-Picryl-Hydrazyl (DPPH) Radical Scavenging Activity—Possible Application in Clinical Studies on Dietary Antioxidants. Clinical Chemical Laboratory Medicine, 46, 342-349. &gt;https://doi.org/10.1515/cclm.2008.062
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nosratabadi, S.F., Sariri, R., Yaghmaei, P., Taheri, M., Ghadimi, A. and Ghafoori, H. (2012) Alternations of Antioxidant Activity in Saliva in Smokers. Journal of Physical and Theorical Chemistry, 8, 305-310.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Catalá, A. and Díaz, M. (2016) Editorial: Impact of Lipid Peroxidation on the Physiology and Pathophysiology of Cell Membranes. Frontiers in Physiology, 7, Article No. 423. &gt;https://doi.org/10.3389/fphys.2016.00423
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Martin, P. and Friedman, L.S. (1992) Assessment of Liver Function and Diagnostic Studies. In: Freidman, L.S. and Keefe, E.B., Eds., Handbook of Liver Disease, Churchill Livingstone, 1-14.
    </mixed-citation>
   </ref>
   <ref id="scirp.138452-ref30">
    <label>30</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Li, X. (2010) Mechanism Underlying Carbon Tetrachloride-Inhibited Protein Synthesis in Liver. World Journal of Gastroenterology, 16, 3950-3956. &gt;https://doi.org/10.3748/wjg.v16.i31.3950
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>